Any feedback?
Literature summary for 3.5.1.104 extracted from
- Variations of N-acetylation level of peptidoglycan do not influence persistence of Lactococcus lactis in the gastrointestinal tract (2010), Int. J. Food Microbiol., 144, 29-34.
Application
| Application | Comment | Organism |
|---|---|---|
| medicine | construction of a mutant pgdA strain and a pgdA-overexpressing strain and comparison of the pharmacokinetics properties of these recombinant strains with that of a wild-type strain, all producing the same model antigen, the human papillomavirus type-16 E7 protein, in the gastrointestinal tract of mice. There is no correlation between survival, at the ileum level, of bacteria intragastrically administered in mice and bacteria sensitivity or resistance to lysozyme. Neither lysozyme-sensitive nor lysozyme-resistant phenotype in Lactococcus lactis enhances significantly the potential of this bacterium as mucosal delivery live vector | Lactococcus lactis |
Organism
| Organism | UniProt | Comment | Textmining |
|---|---|---|---|
| Lactococcus lactis | - |
- |
- |
General Information
| General Information | Comment | Organism |
|---|---|---|
| physiological function | construction of a mutant pgdA strain and a pgdA-overexpressing strain and comparison of the pharmacokinetics properties of these recombinant strains with that of a wild-type strain, all producing the same model antigen, the human papillomavirus type-16 E7 protein, in the gastrointestinal tract of mice. There is no correlation between survival, at the ileum level, of bacteria intragastrically administered in mice and bacteria sensitivity or resistance to lysozyme. Neither lysozyme-sensitive nor lysozyme-resistant phenotype in Lactococcus lactis enhances significantly the potential of this bacterium as mucosal delivery live vector | Lactococcus lactis |
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
Legal
Curated at
Member of
